drug
onabotulinumtoxinA
Marketedupdated 5mo agoby Allergan Sales LLC
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying onabotulinumtoxinA
- phase1A Study to Evaluate Sequential Administration of Injections of AGN-151586 Followed by BOTOX in Adult Participants for Treatment of Glabellar Lines
- phase3A Study to Assess BOTOX Injections for the Change of Masseter Muscle Prominence in Adult Participants
- phase3A Phase 3 Clinical Study to Evaluate the Efficacy and Safety of Botulinum Toxin Type A for Injection (CU-20101)
- phase3Evaluation of Botulinum Toxin Injection Efficacy in the Treatment of Head Essential Tremor
- phase4A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of OnabotulinumtoxinA, JUVÉDERM® Products, KYBELLA, CoolSculpting Elite and SkinMedica Products
- phase3A Clinical Study on Recombinant Botulinum Toxin Type A (YY001) for Injection in The Treatment of Upper Limb Spasticity in Adults
- phase2Study of BOTOX Injections to Assess Change in Disease Symptoms in Adult Participants With Upper Limb Essential Tremor
- phase1Phase 1 Trial of JTM201 in Subjects With Post-stroke Upper Limb Spasticity
News(3)
- New guidelines on migraine prevention reflect increasing options for patients“There has been a wealth of new treatment available” for migraine prevention, said a co-author of new guidelines released Monday.stat · 1mo ago
- ARPA-H puts $160M into bespoke drug therapies; Biohaven switches up scientific leadershipThe ARPA-H program could provide researchers with a roadmap to develop personalized gene editing drugs. Elsewhere, a Botox rival succeeded against migraines and two deals were struck.biopharma_dive · 2mo ago
- Predicting consequences of new hepatitis B vaccine recsNew data on public trust in science, AI and mental health, and other news from Morning Roundsstat · 5mo ago
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that